<?xml version="1.0" encoding="UTF-8"?>
<ref id="pntd.0008336.ref065">
 <label>65</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Baljevic</surname>
   <given-names>M</given-names>
  </name>, 
  <name>
   <surname>Orlowski</surname>
   <given-names>RZ</given-names>
  </name>. 
  <article-title>Pharmacodynamics and pharmacokinetics of proteasome inhibitors for the treatment of multiple myeloma.</article-title>
  <source>Expert Opin Drug Metab Toxicol</source>. 
  <year>2019</year>;
  <volume>15</volume>(
  <issue>6</issue>):
  <fpage>459</fpage>â€“
  <lpage>73</lpage>. 
  <pub-id pub-id-type="doi">10.1080/17425255.2019.1621839</pub-id>
  <?supplied-pmid 31104525?>
  <pub-id pub-id-type="pmid">31104525</pub-id>
 </mixed-citation>
</ref>
